PHP
BSX icon

Parkman Healthcare Partners’s Boston Scientific BSX Stock Holding History

Parkman Healthcare Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.7M Sell
180,481
-268,287
-60% -$14.6M 0.79% 46
2026
Q1 		$28.2M Sell
448,768
-51,761
-10% -$4.14M 2.9% 8
2025
Q4 		$47.7M Buy
500,529
+66,152
+15% +$6.49M 4.54% 1
2025
Q3 		$42.4M Buy
434,377
+151,211
+53% +$15.7M 4.42% 2
2025
Q2 		$30.4M Buy
283,166
+57,176
+25% +$5.79M 3.5% 3
2025
Q1 		$22.8M Sell
225,990
-111,364
-33% -$11.2M 2.7% 10
2024
Q4 		$30.1M Sell
337,354
-109,842
-25% -$9.67M 4.01% 4
2024
Q3 		$37.5M Sell
447,196
-104,396
-19% -$8.23M 4.78% 1
2024
Q2 		$42.5M Buy
551,592
+126,119
+30% +$9.23M 5.69% 1
2024
Q1 		$29.1M Sell
425,473
-227,330
-35% -$14.6M 3.58% 3
2023
Q4 		$37.7M Buy
652,803
+55,543
+9% +$2.96M 5.32% 1
2023
Q3 		$31.5M Buy
597,260
+124,155
+26% +$6.51M 5.78% 1
2023
Q2 		$25.6M Buy
473,105
+44,874
+10% +$2.34M 4.44% 2
2023
Q1 		$21.4M Buy
428,231
+60,298
+16% +$2.84M 4.66% 3
2022
Q4 		$17M Buy
367,933
+20,146
+6% +$872K 4.53% 2
2022
Q3 		$13.5M Buy
+347,787
New +$14M 3.83% 4
2020
Q1 		– Sell
-275,000
Closed -$12.4M – 69
2019
Q4 		$12.4M Buy
+275,000
New +$11.5M 3.59% 6

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Parkman Healthcare Partners's BSX Position: Q2 2026 in Review

Parkman Healthcare Partners reduced its Boston Scientific (BSX) stake by 60% in Q2 2026, selling an estimated $14.6M and leaving 180,481 shares worth $7.7M. The position accounts for 0.79% of the portfolio, ranked #46.

Parkman Healthcare Partners first reported a position in BSX in Q4 2019 and has held it in 17 quarters since. The position peaked at $47.7M in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Parkman Healthcare Partners held 180,481 shares of Boston Scientific worth $7.7M as of Q2 2026.
  • Parkman Healthcare Partners sold 268,287 Boston Scientific shares in Q2 2026, an estimated $14.6M.
  • Boston Scientific made up 0.79% of Parkman Healthcare Partners's portfolio in Q2 2026, its #46 holding.
  • Parkman Healthcare Partners first reported a position in Boston Scientific in Q4 2019 and has held it in 17 quarters since.
  • Parkman Healthcare Partners's Boston Scientific position peaked at $47.7M in Q4 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.